Antigenic and biochemical studies of influenza viruses isolated in defined community epidemics have allowed the development of a new experimental inactivated vaccine.
Oxford
J S
JS
Department of Medical Microbiology, London Hospital Medical College, UK.
D000595:Amino Acid Sequence; D000818:Animals; D000956:Antigens, Viral / Q000276:immunology*; D004196:Disease Outbreaks; D006801:Humans; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000453:epidemiology / Q000517:prevention & control*; D008969:Molecular Sequence Data; D009975:Orthomyxoviridae / Q000276:immunology* / Q000302:isolation & purification; D006113:United Kingdom / Q000453:epidemiology; D015164:Vaccines, Inactivated
D000956:Antigens, Viral; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated